Current understanding of Alzheimer’s disease diagnosis and treatment

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · see citing works

Diagnostic and Statistical Manual of Mental Disorders

Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,468 · see citing works

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · see citing works

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works

Mechanisms of Gamma Oscillations

Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796 · see citing works

The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease

Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,630 · see citing works

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049 · see citing works

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960 · see citing works

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668 · see citing works

Gamma frequency entrainment attenuates amyloid load and modifies microglia

Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328 · see citing works

2017 Alzheimer's disease facts and figures

(, T. D. B. T. A.-R. C. C. A. S. O. A. C. B. S., different, ). J. A. I. A., destroyed, S. A. T. A. S. T. M. E. T. M. C. I. S. I. A. G. W. A. T. R. N. I. T. O. B. T. F. N. T. B. D. A. D. A. U. I. B. R. I. I. F. N. M. A. N. I. O. P. O. T. B. A. D. A., difficulties, I. E. O., agitation, I. N. S. S. A., & delusions., S. A. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,322 · see citing works

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Honig, L. S., Vellas, B., Woodward, M., Boada, M., Bullock, R., Borrie, M., Hager, K., Andreasen, N., Scarpini, E., Liu-Seifert, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705971 · Cited by 1,049 · see citing works

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Clark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855 · see citing works

Donepezil and memantine for moderate-to-severe Alzheimer's disease

Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782 · see citing works

Alzheimer’s disease prevention: from risk factors to early intervention

Crous‐Bou, M., Minguillón, C., Gramunt, N., & Molinuevo, J. L. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0297-z · Cited by 689 · see citing works

Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Singh, B., Parsaik, A. K., Mielke, M. M., Erwin, P. J., Knopman, D. S., Petersen, R. C., & Roberts, R. O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130830 · Cited by 667 · see citing works

Vitamin D and the risk of dementia and Alzheimer disease

Littlejohns, T. J., Henley, W., Lang, I., Annweiler, C., Beauchet, O., Chaves, P. H. M., Fried, L. F., Kestenbaum, B. R., Kuller, L. H., Langa, K. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000755 · Cited by 573 · see citing works

The road to restoring neural circuits for the treatment of Alzheimer's disease

Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565 · see citing works

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

Hampel, H. J., Bürger, K., Teipel, S. J., Bokde, A. L. W., Zetterberg, H., & Blennow, K. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.08.006 · Cited by 532 · see citing works

Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review

Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I. A., Ukoumunne, O. C., & Llewellyn, D. J. (2013) · Epidemiology · doi:10.1097/ede.0b013e3182944410 · Cited by 521 · see citing works

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

Kennedy, M. E., Stamford, A. W., Chen, X., Cox, K., Cumming, J. N., Dockendorf, M. F., Egan, M. F., Ereshefsky, L., Hodgson, R. A., Hyde, L. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9704 · Cited by 432 · see citing works

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Vassar, R. J. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0089-7 · Cited by 413 · see citing works

Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association

Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411 · see citing works

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

Palmqvist, S., Zetterberg, H., Mattsson, N., Johansson, P., Initiative, F. T. A. D. N., Minthon, L., Blennow, K., Olsson, M., For the Swedish BioFINDER study group, Hansson, O., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001991 · Cited by 375 · see citing works

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

Novák, P., Schmidt, R., Kontseková, E., Žilka, N., Kováčech, B., Škrabana, R., Kazmerova, Z., Katina, S., Fialová, Ľ., Prčina, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30331-3 · Cited by 306 · see citing works

Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America

Takizawa, C., Thompson, P. L., van Walsem, A., Faure, C., & Maier, W. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141134 · Cited by 253 · see citing works

Tau immunotherapy for Alzheimer's disease

Pedersen, J. T., & Sigurdsson, E. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.003 · Cited by 247 · see citing works

Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial

Lee, L. K., Shahar, S., Chin, A.-V., & Yusoff, N. A. M. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2848-0 · Cited by 219 · see citing works

Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

Dong, H., Li, J., Huang, L., Chen, X., Li, D., Wang, T., Hu, C., Xu, J. L., Zhang, C., Zen, K., et al. (2015) · Disease Markers · doi:10.1155/2015/625659 · Cited by 214 · see citing works

Beta-amyloid imaging with florbetaben

Sabri, O., Seibyl, J., Rowe, C., & Barthel, H. (2015) · Clinical and translational imaging · doi:10.1007/s40336-015-0102-6 · Cited by 167 · see citing works

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

Grossberg, G. T., Manes, F. F., Allegri, R., Gutiérrez‐Robledo, L. M., Gloger, S., Xie, L., Jia, X., Pejović, V., Miller, M. L., Perhach, J. L., et al. (2013) · CNS Drugs · doi:10.1007/s40263-013-0077-7 · Cited by 158 · see citing works

Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease

Smith, J. C., Nielson, K. A., Woodard, J. L., Seidenberg, M., Durgerian, S., Hazlett, K. E., Figueroa, C. M., Kandah, C. C., Kay, C. D., Matthews, M. A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00061 · Cited by 156 · see citing works

Gamma Oscillations Distinguish True From False Memories

Sederberg, P. B., Schulze‐Bonhage, A., Madsen, J. R., Bromfield, E. B., Litt, B., Brandt, A., & Kahana, M. J. (2007) · Psychological Science · doi:10.1111/j.1467-9280.2007.02003.x · Cited by 153 · see citing works

The n-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial

Bo, Y., Zhang, X., Wang, Y., You, J., Cui, H., Zhu, Y., Pang, W., Liu, W. Y., Jiang, Y., & Lü, Q. (2017) · Nutrients · doi:10.3390/nu9010054 · Cited by 133 · see citing works

Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets

Pooler, A. M., Polydoro, M., Wegmann, S., Nicholls, S. B., Spires‐Jones, T. L., & Hyman, B. T. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt214 · Cited by 123 · see citing works

Increased plasma beta-secretase 1 may predict conversion to Alzheimer’s disease dementia in individuals with mild cognitive impairment

Shen, Y., Wang, H., Sun, Q., Yao, H., Keegan, A. P., Mullan, M., Wilson, J., Lista, S., Leyhe, T., Laske, C., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.007 · Cited by 123 · see citing works

Huperzine A in the Treatment of Alzheimer′s Disease and Vascular Dementia: A Meta‐Analysis

Xing, S.-H., Zhu, C., Zhang, R., & An, L. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/363985 · Cited by 117 · see citing works

Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy

Panza, F., Solfrizzi, V., Seripa, D., Imbimbo, B. P., Lozupone, M., Santamato, A., Tortelli, R., Galizia, I., Prete, C., Daniele, A., et al. (2016) · Immunotherapy · doi:10.2217/imt-2016-0019 · Cited by 104 · see citing works

Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APP London Mice

Jacobsen, H., Ozmen, L., Caruso, A., Narquizian, R., Hilpert, H., Jacobsen, B., Terwel, D., Tanghe, A., & Bohrmann, B. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1405-14.2014 · Cited by 97 · see citing works

A systematic review and meta‐analysis of 18F‐labeled amyloid imaging in Alzheimer's disease

Yeo, J. M., Waddell, B., Khan, Z. H., & Pal, S. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.004 · Cited by 78 · see citing works

Leisure-time physical activity over the life course and cognitive functioning in late mid-adult years: a cohort-based investigation

Dregan, A., & Gulliford, M. C. (2013) · Psychological Medicine · doi:10.1017/s0033291713000305 · Cited by 72 · see citing works

Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial

Stella, F., Canonici, A. P., Gobbi, S., Galduróz, J. C. F., Cação, J. D. C., & Gobbi, L. T. B. (2011) · Clinics · doi:10.1590/s1807-59322011000800008 · Cited by 65 · see citing works

New Criteria for Alzheimer Disease and Mild Cognitive Impairment

Budson, A. E., & Solomon, P. R. (2012) · The Neurologist · doi:10.1097/nrl.0b013e31826a998d · Cited by 65 · see citing works

Building a roadmap for developing combination therapies for Alzheimer’s disease

Perry, D. P., Sperling, R. A., Katz, R. G., Berry, D. A., Dilts, D. M., Hanna, D. L., Salloway, S., Trojanowski, J. Q., Bountra, C., Krams, M., et al. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.996551 · Cited by 54 · see citing works

Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

Rosenmann, H. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310030001 · Cited by 52 · see citing works

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients

Saint‐Aubert, L., Barbeau, E. J., Péran, P., Nemmi, F., Vervueren, C., Mirabel, H., Payoux, P., Hitzel, A., Bonneville, F., Gramada, R., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-43 · Cited by 49 · see citing works

Management of patients with Alzheimer’s disease: pharmacological treatment and quality of life

Mossello, E., & Ballini, E. (2012) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622312452387 · Cited by 48 · see citing works

Role of Traditional Nonsteroidal Anti-inflammatory Drugs in Alzheimer’s Disease

Gupta, P. P., Pandey, R. D., Jha, D., Shrivastav, V. K., & Kumar, S. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514542644 · Cited by 46 · see citing works

EU/US/CTAD TASK FORCE: LESSONS LEARNED FROM RECENT AND CURRENT ALZHEIMER’S PREVENTION TRIALS

Aisen, P. S. S., Touchon, J., Amariglio, R. E., Andrieu, S., Bateman, R. J., Breitner, J. C. S., Donohue, M. A., Dunn, B., Doody, R. S., Fox, N. C., et al. (2017) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.13 · Cited by 42 · see citing works

Amyloid or tau: the chicken or the egg?

Mann, D. M. A., & Hardy, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1162-1 · Cited by 37 · see citing works

Reply: the early pathological process in sporadic Alzheimer’s disease

Braak, H., & Tredici, K. D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1170-1 · Cited by 32 · see citing works

Diseases: Study neuron networks to tackle Alzheimer's

Kosik, K. S. (2013) · Nature · doi:10.1038/503031a · Cited by 15 · see citing works

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820 · see citing works

Molecular mechanisms of ferroptosis and their involvement in brain diseases

Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402 · see citing works

The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications

Arranz, A. M., & Strooper, B. D. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30490-3 · Cited by 348 · see citing works

Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs

Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115522 · Cited by 358 · see citing works

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?

Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323 · see citing works

The complexity of Alzheimer’s disease: an evolving puzzle

Ferrari, C., & Sorbi, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00015.2020 · Cited by 324 · see citing works

Biosensing based on field-effect transistors (FET): Recent progress and challenges

Sadighbayan, D., Hasanzadeh, M., & Ghafar‐Zadeh, E. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116067 · Cited by 309 · see citing works

Intrinsically Disordered Proteins: An Overview

Trivedi, R., & Nagarajaram, H. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214050 · Cited by 253 · see citing works

Advances in the development of new biomarkers for Alzheimer’s disease

Klyucherev, T. O., Olszewski, P., Shalimova, A. A., Chubarev, V. N., Tarasov, V. V., Attwood, M. M., Syvänen, S., & Schiöth, H. B. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00296-z · Cited by 241 · see citing works

Microglia and Alzheimer’s Disease

Merighi, S., Nigro, M., Travagli, A., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112990 · Cited by 236 · see citing works

A review on advances of treatment modalities for Alzheimer's disease

Thoe, E. S., Fauzi, A., Tang, Y.-Q., Chamyuang, S., & Chia, A. Y. Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119129 · Cited by 224 · see citing works

Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

Zhang, W., Xu, C., Sun, J., Shen, H., Wang, J., & Yang, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.008 · Cited by 213 · see citing works

Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications

Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207 · see citing works

Plant‐Based Synthesis of Zinc Oxide Nanoparticles (ZnO‐NPs) Using Aqueous Leaf Extract of Aquilegia pubiflora : Their Antiproliferative Activity against HepG2 Cells Inducing Reactive Oxygen Species and Other In Vitro Properties

Jan, H., Shah, M., Andleeb, A., Faisal, S., Khattak, A., Rizwan, M., Drouet, S., Hano, C., & Abbasi, B. H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4786227 · Cited by 182 · see citing works

Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia

Agrawal, I., & Jha, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00252 · Cited by 181 · see citing works

The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases

DeMaio, A., Mehrotra, S., Sambamurti, K., & Husain, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02605-9 · Cited by 184 · see citing works

Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach

Zarneshan, S. N., Fakhri, S., & Khan, H. Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106099 · Cited by 175 · see citing works

High-intensity interval training ameliorates Alzheimer's disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization

Feng, S., Wu, C., Zou, P., Deng, Q., Chen, Z., Li, M., Zhu, L., Li, F., Liu, T. C., Duan, R., et al. (2023) · Theranostics · doi:10.7150/thno.81951 · Cited by 170 · see citing works

The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders

Tripathi, M. K., Kartawy, M., & Amal, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101567 · Cited by 161 · see citing works

Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease

Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 146 · see citing works

The Endosomal Recycling Pathway—At the Crossroads of the Cell

O’Sullivan, M. J., & Lindsay, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176074 · Cited by 131 · see citing works

Biosensors Based on Mechanical and Electrical Detection Techniques

Chalklen, T., Jing, Q., & Kar‐Narayan, S. (2020) · Sensors · doi:10.3390/s20195605 · Cited by 138 · see citing works

Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer’s disease in rats

Chen, X., Zhang, M., Ahmed, M., Surapaneni, K. M., Veeraraghavan, V. P., & Arulselvan, P. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.06.031 · Cited by 129 · see citing works

Expert systems: Definitions, advantages and issues in medical field applications

Saibene, A., Assale, M., & Giltri, M. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.114900 · Cited by 133 · see citing works

Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies

Zhang, X., Chen, J., Ouyang, D., & Lu, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020493 · Cited by 125 · see citing works

DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases

Kousparou, C. A., Fyrilla, M., Stephanou, A., & Patrikios, I. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310717 · Cited by 123 · see citing works

Curcuma longa Mediated Synthesis of Copper Oxide, Nickel Oxide and Cu-Ni Bimetallic Hybrid Nanoparticles: Characterization and Evaluation for Antimicrobial, Anti-Parasitic and Cytotoxic Potentials

Faisal, S., Al‐Radadi, N. S., Jan, H., Abdullah, A., Shah, S. A., Shah, S., Rizwan, M., Afsheen, Z., Hussain, Z., Uddin, M. N., et al. (2021) · Coatings · doi:10.3390/coatings11070849 · Cited by 118 · see citing works

Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases

Nand, S., Mishra, D., Singh, P., Vamanu, E., & Singh, M. P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111377 · Cited by 116 · see citing works

New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease

Wu, J., Yu, Y., Wan, Y., Xia, J., Xu, J., Zhang, L., Liu, D., Chen, L., Tang, F., Ao, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113207 · Cited by 115 · see citing works

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications

Leinen, Z. J., Mohan, R., Premadasa, L. S., Acharya, A., Mohan, M., & Byrareddy, S. N. (2023) · Biomedicines · doi:10.3390/biomedicines11102630 · Cited by 114 · see citing works

The Cognitive Control of Eating and Body Weight: It’s More Than What You “Think”

Davidson, T. L., Jones, S., Roy, M., & Stevenson, R. J. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00062 · Cited by 114 · see citing works

The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration

Pisani, A., Paciello, F., VECCHIO, V. D., Malesci, R., Corso, E. D., Cantone, E., & Fetoni, A. R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040652 · Cited by 120 · see citing works

Electrochemical detection of dopamine with negligible interference from ascorbic and uric acid by means of reduced graphene oxide and metals-NPs based electrodes

Patella, B., Sortino, A., Mazzara, F., Aiello, G., Drago, G., Torino, C., Vilasi, A. D., O'Riordan, A. J., & Inguanta, R. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339124 · Cited by 109 · see citing works

Deep learning-based EEG analysis to classify normal, mild cognitive impairment, and dementia: Algorithms and dataset

Kim, M., Youn, Y. C., & Paik, J. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120054 · Cited by 109 · see citing works

Ubiquitous protein lactylation in health and diseases

Wang, J., Wang, Z., Wang, Q., Li, X., & Guo, Y. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00541-5 · Cited by 109 · see citing works

Beyond the average patient: how neuroimaging models can address heterogeneity in dementia

Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106 · see citing works

Deep learning of resting-state electroencephalogram signals for three-class classification of Alzheimer’s disease, mild cognitive impairment and healthy ageing

Huggins, C. J., Escudero, J., Parra, M. A., Scally, B., Anghinah, R., Vitória Lacerda De Araújo, A., Basile, L. F., & Abasolo, D. (2021) · Journal of Neural Engineering · doi:10.1088/1741-2552/ac05d8 · Cited by 105 · see citing works

Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's

Nirale, P., Paul, A., & Yadav, K. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117394 · Cited by 103 · see citing works

A comparison of resting state EEG and structural MRI for classifying Alzheimer’s disease and mild cognitive impairment

Farina, F. R., Emek‐Savaş, D. D., Rueda‐Delgado, L. M., Boyle, R. T., Kiiski, H. S. M., Yener, G., & Whelan, R. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116795 · Cited by 105 · see citing works

Dioscin alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation

Guan, L., Mao, Z., Yang, S., Wu, G., Chen, Y., Yin, L., Qi, Y., Han, L., & Xu, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113248 · Cited by 100 · see citing works

Immunotherapy for Parkinson’s disease

Schwab, A. D., Thurston, M. J., Machhi, J., Olson, K. E., Namminga, K. L., Gendelman, H. E., & Mosley, R. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104760 · Cited by 98 · see citing works

P‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?

Chai, A. B., Leung, G. K. F., Callaghan, R., & Gelissen, I. C. (2019) · FEBS Journal · doi:10.1111/febs.15148 · Cited by 98 · see citing works

Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer’s disease: Past, present and future

Gouveia, F., Camins, A., Ettcheto, M., Bicker, J., Falcão, A. C., Cruz, M. T., & Fortuna, A. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101612 · Cited by 96 · see citing works

Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs

Thakral, S., Yadav, A., Singh, V., Kumar, M., Kumar, P., Narang, R., Sudhakar, K., Verma, A., Khalilullah, H., Jaremko, M., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101960 · Cited by 99 · see citing works

Oligodendroglial Cells in Alzheimer’s Disease

Butt, A. M., Rocha, I. C. D. L., & Rivera, A. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_12 · Cited by 94 · see citing works

Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis

Garbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2021) · Molecular Biology · doi:10.1134/s002689332104004x · Cited by 95 · see citing works

Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease

Zheng, M., & Wang, P. (2021) · 3 Biotech · doi:10.1007/s13205-021-02738-3 · Cited by 98 · see citing works

Optimization of VGG16 utilizing the Arithmetic Optimization Algorithm for early detection of Alzheimer’s disease

Deepa, N., & Chokkalingam, S. P. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103455 · Cited by 92 · see citing works

A monomeric polysaccharide from Polygonatum sibiricum improves cognitive functions in a model of Alzheimer's disease by reshaping the gut microbiota

Luo, S., Zhang, X., Huang, S. Q., Feng, X., Zhang, X., & Xiang, D.-X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.185 · Cited by 92 · see citing works

LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease

Zhou, Y., Ge, Y., Liu, Q., Li, Y., Xu, C., Guan, J., Diwu, Y., & Zhang, Q. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.10.028 · Cited by 91 · see citing works

Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders

Moya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 88 · see citing works

Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases

Xia, X., Wang, Y., & Zheng, J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.003 · Cited by 87 · see citing works

Bio-Catalytic Activity of Novel Mentha arvensis Intervened Biocompatible Magnesium Oxide Nanomaterials

Faisal, S., Abdullah, A., Jan, H., Shah, S. A., Shah, S., Rizwan, M., Zaman, N., Hussain, Z., Uddin, M. N., Bibi, N., et al. (2021) · Catalysts · doi:10.3390/catal11070780 · Cited by 86 · see citing works

Mesenchymal Stem Cell Therapy for Alzheimer’s Disease

Hernández, A., & García, E. (2021) · Stem Cells International · doi:10.1155/2021/7834421 · Cited by 88 · see citing works

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis

Mimura, Y., Nishida, H., Nakajima, S., Tsugawa, S., Morita, S., Yoshida, K., Tarumi, R., Ogyu, K., Wada, M., Kurose, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.003 · Cited by 85 · see citing works

Speech- and language-based classification of Alzheimer's disease: a systematic review

Vigo, I., Coelho, L., & Reis, S. (2022) · Bioengineering · doi:10.3390/bioengineering9010027 · Cited by 83 · see citing works

The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta‐analysis of cohort studies

Wee, J., Sukudom, S., Bhat, S., Marklund, M., Peiris, N. J., Hoyos, C. M., Patel, S., Naismith, S. L., Dwivedi, G., & Misra, A. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12395 · Cited by 82 · see citing works

Unlocking the Potential of XAI for Improved Alzheimer’s Disease Detection and Classification Using a ViT-GRU Model

Mahim, S. M., Ali, M. S., Hasan, M. O., Nafi, A. A. N., Sadat, A. K. M., Hasan, S. A., Shareef, B., Ahsan, M. M., Islam, M. K., Miah, M. S., et al. (2024) · IEEE Access · doi:10.1109/access.2024.3351809 · Cited by 83 · see citing works

Mitochondrial Extracellular Vesicles (mitoEVs): Emerging mediators of cell-to-cell communication in health, aging and age-related diseases.

Iorio, R., Petricca, S., Emidio, G. D., Falone, S., & Tatone, C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102522 · Cited by 81 · see citing works

The Links between Cardiovascular Diseases and Alzheimer's Disease

Leszek, J., Вячеславовна, М. Е., Belousov, D. M., Koutsouraki, E., Szczechowiak, K., Kobusiak−Prokopowicz, M., Mysiak, A., Diniz, B. S., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729093724 · Cited by 84 · see citing works

Machine Learning Algorithms and Statistical Approaches for Alzheimer’s Disease Analysis Based on Resting-State EEG Recordings: A Systematic Review

Tzimourta, K. D., Christou, V., Tzallas, A. T., Giannakeas, N., Astrakas, L. G., Angelidis, P., Tsalikakis, D., & Tsipouras, M. G. (2021) · International Journal of Neural Systems · doi:10.1142/s0129065721300023 · Cited by 78 · see citing works

Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases

Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s347187 · Cited by 80 · see citing works

An Attention-Based 3D CNN With Multi-Scale Integration Block for Alzheimer's Disease Classification

Wu, Y., Zhou, Y., Zeng, W., Qian, Q., & Song, M. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3197331 · Cited by 78 · see citing works

O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease

Park, J., Lai, M. K. P., Arumugam, T. V., & Jo, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08584-0 · Cited by 75 · see citing works

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease

Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 76 · see citing works

DeepCurvMRI: Deep Convolutional Curvelet Transform-Based MRI Approach for Early Detection of Alzheimer’s Disease

Chabib, C., Hadjileontiadis, L. J., & Shehhi, A. A. (2023) · IEEE Access · doi:10.1109/access.2023.3272482 · Cited by 72 · see citing works

Mitochondrial RNA in Alzheimer’s Disease Circulating Extracellular Vesicles

Kim, K. M., Meng, Q., de Acha, O. P., Mustapić, M., Cheng, A., Eren, E., Kundu, G., Piao, Y.-L., Munk, R., Wood, W., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581882 · Cited by 66 · see citing works

Phytotherapy: A promising approach for the treatment of Alzheimer's disease

John, O. O., Amarachi, I. S., Chinazom, A. P., Adaeze, E., Kale, M. B., Umare, M. D., & Upaganlawar, A. B. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100030 · Cited by 69 · see citing works

DL0410 attenuates oxidative stress and neuroinflammation via BDNF/TrkB/ERK/CREB and Nrf2/HO-1 activation

Zhang, B., Zhao, J., Wang, Z., Xu, L., Liu, A., & Du, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106729 · Cited by 69 · see citing works

Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies

Londzin, P., Zamora, M., Kąkol, B., Taborek, A., & Folwarczna, J. (2021) · Nutrients · doi:10.3390/nu13020537 · Cited by 71 · see citing works

Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer’s disease

Jayaswamy, P. K., Vijaykrishnaraj, M., Patil, P., Alexander, L. M., Kellarai, A., & Shetty, P. K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101791 · Cited by 69 · see citing works

Potential Role of Phytochemical Extract from Saffron in Development of Functional Foods and Protection of Brain‐Related Disorders

Maqbool, Z., Arshad, M. S., Ali, A., Aziz, A., Khalid, W., Afzal, M. F., Bangar, S. P., Addi, M., Hano, C., & Lorenzo, J. M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6480590 · Cited by 67 · see citing works

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 66 · see citing works

Did the Brain and Oral Microbiota Talk to Each Other? A Review of the Literature

Maitre, Y., Micheneau, P., Delpierre, A., Mahalli, R., Guérin, M., Amador, G., & Denis, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123876 · Cited by 65 · see citing works

Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer’s Disease

Blagov, A. V., Grechko, A. V., Nikiforov, N. G., Borisov, E. E., Sadykhov, N. K., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136954 · Cited by 65 · see citing works

Associations Between Diabetes Mellitus and Neurodegenerative Diseases

Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 74 · see citing works

Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic

Cordeiro, M. F., Hill, D., Patel, R. P., Corazza, P., Maddison, J., & Younis, S. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100976 · Cited by 64 · see citing works

Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease

Yamamoto, Y., Kanayama, N., Nakayama, Y., & Matsushima, N. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030444 · Cited by 66 · see citing works

Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier

Beygi, M. H. M., Oroojalian, F., Azizi‐Arani, S., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202310881 · Cited by 65 · see citing works

Amyloid-β: A double agent in Alzheimer's disease?

Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62 · see citing works

Impact of Alzheimer’s Disease on Caregivers in the United States

Vu, M., Mangal, R., Stead, T., Carlos Lopez-Ortiz, C., & Ganti, L. (2022) · Health Psychology Research · doi:10.52965/001c.37454 · Cited by 62 · see citing works

Regulation and mechanism of Astragalus polysaccharide on ameliorating aging in Drosophila melanogaster

Li, X., Yang, S., Wang, S., Shi, Y., Dai, Y., Zhang, X., Liu, Y., Guo, Y., He, J., & Xiu, M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123632 · Cited by 62 · see citing works

The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review

Buglio, D. S., Marton, L. T., Laurindo, L. F., Guiguer, É. L., Araújo, A. C., Buchaim, R. L., Goulart, R. D. Á., Rubira, C. J., & Barbalho, S. M. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.0084 · Cited by 61 · see citing works

Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives

Abdullah, S. A., Najm, L., Ladouceur, L., Ebrahimi, F., Shakeri, A., Al‐Jabouri, N., Didar, T. F., & Dellinger, K. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302673 · Cited by 61 · see citing works

Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer’s Disease

Zhang, L., Qi, Z., Li, J., Li, M., Du, X., Wang, S., Zhou, G., Xu, B., Liu, W., Xi, S., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02311-2 · Cited by 57 · see citing works

Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2

Galla, L., Redolfi, N., Pozzan, T., Pizzo, P., & Greotti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030770 · Cited by 58 · see citing works

Hierarchical Porous Carbon—PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer’s Disease Therapy

Nanaki, S. G., Spyrou, K., Bekiari, C., Veneti, P., Baroud, T. N., Karouta, N., Grivas, I. N., Papadopoulos, G. C., Gournis, D., & Bikiaris, D. Ν. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030227 · Cited by 57 · see citing works

Learning Language and Acoustic Models for Identifying Alzheimer’s Dementia From Speech

Shah, Z., Sawalha, J., Tasnim, M., Qi, S.-A., Stroulia, E., & Greiner, R. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2021.624659 · Cited by 56 · see citing works

lncRNA XIST induces Aβ accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer’s disease

Yan, X., Liu, H., Hong, Y.-X., Meng, T., Du, J., & Chang, C. (2022) · Journal of Neurogenetics · doi:10.1080/01677063.2022.2028784 · Cited by 56 · see citing works

Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases

Gianferrara, T., Cescon, E., Grieco, I., Spalluto, G., & Federico, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220216113517 · Cited by 57 · see citing works

Treating disorders across the lifespan by modulating cholinergic signaling with galantamine

Metz, C. N., & Pavlov, V. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15243 · Cited by 55 · see citing works

Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity

Qi, C., Chen, X.-X., Gao, X., Xu, J., Liu, S., & Ge, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.633495 · Cited by 54 · see citing works

Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?

Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 56 · see citing works

Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles

Kumar, A., Zhou, L., Zhi, K., Raji, B., Pernell, S., Tadrous, E., Kodidela, S., Nookala, A. R., Kochat, H., & Kumar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010138 · Cited by 53 · see citing works

Genetic associated complications of type 2 diabetes mellitus

WONG, Y. H., WONG, S. H., WONG, X. T., YAP, Q. Y., Yip, K. Y., WONG, L. Z., Chellappan, D. K., Bhattamisra, S. K., & Candasamy, M. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04285-3 · Cited by 52 · see citing works

Mitochondria break free: Mitochondria-derived vesicles in aging and associated conditions

Ferrucci, L., Guerra, F., Bucci, C., Marzetti, E., & Picca, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102549 · Cited by 52 · see citing works

The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration

Konopka, A., & Atkin, J. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.836885 · Cited by 51 · see citing works

Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation

Fan, M., Liu, S., Sun, H.-M., Ma, M.-D., Gao, Y.-J., Qi, C.-C., Xia, Q.-R., & Ge, J.-F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113375 · Cited by 50 · see citing works

Plasma microRNAs as potential biomarkers in early Alzheimer disease expression

Peña‐Bautista, C., Tarazona-Sánchez, A., Braza‐Boïls, A., Balaguer, Á., Ferré‐González, L., Martínez, A. J. C., Baquero, M., & Cháfer‐Pericás, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-19862-6 · Cited by 51 · see citing works

Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice

Patel, C. A., Pande, S. V., & Acharya, S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01904-3 · Cited by 51 · see citing works

ALZHEIMER'S DISEASE: CAUSES AND TREATMENT

1Dr Saniya Khakwani, 2. M. W. B. F. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4407627

The Pathophysiology, Diagnosis and Some Management Approaches of Alzheimer’s Disease: An Overview

Ansari, A. J., Monawwar, M., & Fatima, N. (2021)

Alzheimer’s Disease

Ye, Q. (2022) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.220504.328

The pathology, diagnosis and treatment of Alzheimer’s disease

Zheng, J. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/20/20230741

Clinical Research on Alzheimer’s Disease: Progress and Perspectives

Sun, B., Li, W., Zhu, C., Jin, W., Zeng, F., Liu, Y.-H., Bu, X., Zhu, J., Yao, X., & Wang, Y. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0249-z · Cited by 164 · see citing works